Australian Clinical Labs Limited (ACL.AU) Q3 2024 Earnings

Aug 28Confirmed
Nov 2022
Q4 2022
Q1 2024
Q3 2024
0
0.04
0.07
0.11

Details

Expected EPS
0.07859111340358116
Actual EPS
0.1051156141772898
Surprise EPS
0.03
Surprise Percent
+33.75%

Description

⁨Australian Clinical Labs Limited⁩ (⁦ACL.AU⁩) has reported earnings of ⁦0.1051156141772898⁩ per share for ⁦Q3 2024⁩.

1 Comment

Share your thoughts